Refine by
Crispr Suppliers & Manufacturers
68 companies found
based inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
ioGlutamatergic Neurons have been reprogrammed from human induced pluripotent stem cells (iPSC) using our precise reprogramming technology: opti-ox™¹ (optimized inducible overexpression). Human stem cells, within days, convert into ...
based inHayward,, CALIFORNIA (USA)
If the 20th Century was the age of physics, the 21st Century is the age of biology. Discoveries like optogenetics and CRISPR already allow us to work with single neurons and change the genomes of living cells. Life scientists are revolutionizing our ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Brefeldin A blocks the transport of secreted and membrane proteins from endoplasmic reticulum to Golgi apparatus[1][2]. Brefeldin A is also an autophagy and mitophagy inhibitor[3]. Brefeldin A is a CRISPR/Cas9 activator[5]. ...
based inMorrisville, NORTH CAROLINA (USA)
Locus is a clinical-stage biotechnology company developing precision medicines for therapeutic indications across infectious disease and inflammatory diseases. Once revolutionary, antibiotics are interfering with the effectiveness of novel, ...
CRISPR-Cas3 offers a unique approach to human genome editing with the ability to produce long-range deletions. Our IP portfolio enables the use of Cas3 human gene editing, a capability that we have been incubating since the ...
based inHolliston, MASSACHUSETTS (USA)
BTX has been at the forefront of electroporation technology since we introduced the first commercially available electroporator in 1983. For over 30 years, we have made it our priority to focus only on electroporation and electrofusion. This focus ...
Get a multifunctional electrofusion and square wave electroporation generator that meets your exact needs. Available product configurations by application, such as embryo manipulation or hybridoma production, make choosing the right system easy. For ...
based inPalo Alto, CALIFORNIA (USA)
SBI is a small biotech company that’s delivered innovative products and services for molecular and cell biology research since January 2004, when we sold our first lentivectors and pPACK lentivirus packaging systems. We focus on being the first ...
Easily verify transfection efficiencies with this All-in-one Cas9 SmartNuclease Plasmid that coordinately expresses RFP- EF1α-T7-hspCas9-T2A-RFP-H1-gRNA. Conveniently deliver Cas9 and gRNA with a single vector. Monitor transfection ...
based inBeijing, CHINA
In 2006, TransGen Biotech Co., Ltd was founded by three scientists with a mission to produce innovative and cost-effective products for life science research. Now TransGen is a leading manufacturer of more than 200 molecular and cellular biology ...
pEASY®-Blunt Cloning Kit is designed for cloning and sequencing Pfu-amplified PCR products. 5 minutes fast ligation of Pfu-amplified PCR products. Kanamycin and Ampicillin resistance genes for selection. Easy blue/white selection. T7 promoter, ...
based inReno, NEVADA (USA)
EchelonDx provides a variety of services to the biotechnology and diagnostics sectors, from bespoke commercial product software for regulated devices and assays, to algorithm development for new products, and statistical consulting for both research ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
Accelerated in vitro evaluation of retinal toxicity. Newcells offers a fast and reliable retinal drug toxicity in vitro testing service using complex models developed in house: retinal organoids and RPE. The retinal toxicity service evaluates how ...
based inCochin, INDIA
SciGenom is an ISO certified company, with a fully functional state-of-the-art molecular biology laboratory in Cochin. Its R&D lab is recognized by Department of Scientific & Industrial Research (DSIR), Ministry of Science & Technology, Government ...
based inParis, FRANCE
Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. Eligo Bioscience was created in 2014 by scientists from Rockefeller University and ...
Eligobiotics are a first-in-class proprietary modality that enables the delivery and expression of therapeutic DNA in target bacterial populations of the microbiome. This technology allows modulation of the microbiome’s composition and ...
based inCambridge, MASSACHUSETTS (USA)
Abcam identifies, develops, and provides high-quality biological reagents and tools which are essential in a wide range of fields and applications including drug discovery, diagnostics and basic research. We supply the global life science community ...
based inManitowoc, WISCONSIN (USA)
Bio-Technical Resources develops new strains, process technologies, and products based on microbial fermentation. We have over 57 years of experience providing services to rapidly develop strains and robust commercial processes in the most ...
BTR microbiologists and molecular biologists have worked with a large spectrum of microorganisms. We have successfully applied two general approaches to strain development: Classic mutagenesis, screening and selection. Advanced recombinant ...
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products ...
Antibodies are one of the most important everyday reagents for biomedical science. In recent years, a number of studies have questioned the reliability of published data and highlighted how low-quality antibodies have contributed to a lack of ...
based inOxford, UNITED KINGDOM
Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics. Backed by leading venture capital groups and ...
The Evox portfolio includes granted and pending applications in the world's major pharmaceutical markets, including USA, Europe, Japan, China as well as various other jurisdictions. In addition to the patent portfolio Evox also safeguards its ...
based inCambridge, MASSACHUSETTS (USA)
Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around ...
EDIT-301 is an experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). EDIT-301 consists of patient-derived CD34+ hematopoietic stem and ...
based inNavi Mumbai, INDIA
Yashraj Biotech Limited manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogens. YBL has been the preferred partner of most of ...
Yashraj Biotechnology Ltd.’s (YBL) offers Development of Primary Cell line(s), both from normal and tumor tissues. YBL offers Transformation of cell lines by introduction of external DNA that drives the Transformation process by sustaining ...
based inBerkeley, CALIFORNIA (USA)
Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell ...
Our chRDNA technology enables multiple genome edits, including multiplex gene insertions, with a high degree of specificity and lower levels of off-target editing than first generation CRISPR-Cas9. ...
based inLyon, FRANCE
Cellenion is a part of BICO. Our products aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry. ...
We offer a range of automated cloning solutions to suit even the most challenging cell line development ...
based inJena, GERMANY
We develop, manufacture and sell high-quality automated solutions for life sciences in a broad range of areas including molecular diagnostics, cancer and stem cell research, cell line development and bioprocessing. Our core competencies are in ...